Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000732665 | SCV000590245 | uncertain significance | not provided | 2017-06-26 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the KCNQ2 gene. The c.1347 C>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.1347 C>T variant is observed in 1/8434 (0.01%) alleles from individuals of East Asian background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Several in-silico splice prediction models predict that c.1347 C>T creates a cryptic donor site which may supplant the natural donor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Eurofins Ntd Llc |
RCV000732665 | SCV000860641 | uncertain significance | not provided | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765495 | SCV000896791 | uncertain significance | Seizures, benign familial neonatal, 1; Developmental and epileptic encephalopathy, 7 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001038432 | SCV001201899 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-17 | criteria provided, single submitter | clinical testing |